MB Diagnostics ApS: Financial statements 2023
CVR: 38185853
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 30,014 and a net result of DKK 9,905 compared with DKK -2,383 the year before. That is an increase of 104.8% compared with the year before. Equity in the 2023 report amounted to DKK 604,949. The solvency ratio was 57.1%.
- Gross Profit
- DKK 30,014
- Profit/Loss
- DKK 9,905
- Equity
- DKK 604,949
- Total Assets
- DKK 1,058,667
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 30 t. | 10 t. | 605 t. | 0 |
| 2022 | - | 15 t. | -2 t. | 713 t. | 0 |
| 2021 | - | 43 t. | 22 t. | 828 t. | 0 |
| 2020 | - | -9 t. | -20 t. | 807 t. | 0 |
| 2019 | - | 586 t. | 448 t. | 827 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MB Diagnostics ApS has published its annual report for 2022. Gross profit came to DKK 14,655, and the net result was DKK -2,383.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.